Skip to main content
Erschienen in: Current Reviews in Musculoskeletal Medicine 2/2017

07.04.2017 | Orthopaedic Health Policy (A Miller, section editor)

Osteoporosis: a discussion on the past 5 years

verfasst von: Kyle M. Schweser, Brett D. Crist

Erschienen in: Current Reviews in Musculoskeletal Medicine | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of the review

The purposes of this study are to examine the literature within the past 5 years regarding osteoporosis and offer a discussion on new topics and controversies.

Recent findings

  • Patient compliance with therapy remains an issue.
  • The effectiveness of Vitamin D and calcium are being called into question
  • Atypical femur fractures have been associated with bisphosphonate and denosumab use. Treatment is both surgical and pharmaceutical.
  • A multidisciplinary approach to osteoporotic fractures is important and having some form of fracture liaison service (FLS) improves the efficacy of osteoporotic care and decreases secondary fractures.
  • Screening for osteoporosis remains low.
  • Ultrasound may be cost-effective for diagnosis.

Summary

Understanding of osteoporosis has come a long way in the medical community, but the translation to the lay community has lagged behind. Patients often take a laissez-faire attitude toward osteoporosis that can affect compliance. Information read by patients often focuses on complications, such as atypical femur fractures and myocardial infarctions. It is essential for providers to be able to discuss these issues with patients. Newer medications and more cost-effective diagnostic tests exist, but availability may be limited. FLS are effective, but the most cost-effective model for therapy still eludes us. Areas for further investigation include FLS models, the effectiveness of vitamin supplementation, and more ubiquitous and cost-effective diagnostic tools.
Literatur
1.
4.
Zurück zum Zitat Arora VM, Prochaska ML, Farnan JM, D’Arcy MJ, Schwanz KJ, Vinci LM, et al. Problems after discharge and understanding of communication with their primary care physicians among hospitalized seniors: a mixed methods study. J Hosp Med. 2010;5(7):385–91. doi:10.1002/jhm.668.CrossRefPubMedPubMedCentral Arora VM, Prochaska ML, Farnan JM, D’Arcy MJ, Schwanz KJ, Vinci LM, et al. Problems after discharge and understanding of communication with their primary care physicians among hospitalized seniors: a mixed methods study. J Hosp Med. 2010;5(7):385–91. doi:10.​1002/​jhm.​668.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Khosla S, Shane E. A crisis in the treatment of osteoporosis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2016;31(8):1485–7. doi:10.1002/jbmr.2888.CrossRef Khosla S, Shane E. A crisis in the treatment of osteoporosis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2016;31(8):1485–7. doi:10.​1002/​jbmr.​2888.CrossRef
7.
Zurück zum Zitat Majumdar SR, McAlister FA, Johnson JA, Weir DL, Bellerose D, Hanley DA, et al. Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014;25(9):2173–9. doi:10.1007/s00198-014-2728-z.CrossRef Majumdar SR, McAlister FA, Johnson JA, Weir DL, Bellerose D, Hanley DA, et al. Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014;25(9):2173–9. doi:10.​1007/​s00198-014-2728-z.CrossRef
9.
10.
Zurück zum Zitat Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing. 2010;39(2):203–9. doi:10.1093/ageing/afp221.CrossRefPubMed Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing. 2010;39(2):203–9. doi:10.​1093/​ageing/​afp221.CrossRefPubMed
11.
Zurück zum Zitat Ikeda S. Hip fracture—epidemiology, management and liaison service. Practice of the secondary fracture prevention of the proximal femoral fracture by the osteoporosis liaison service. Clinical calcium. 2015;25(4):551–8.PubMed Ikeda S. Hip fracture—epidemiology, management and liaison service. Practice of the secondary fracture prevention of the proximal femoral fracture by the osteoporosis liaison service. Clinical calcium. 2015;25(4):551–8.PubMed
13.
Zurück zum Zitat Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney Jr RE, McLellan A, et al. Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res Off J Am Soc Bone Miner Res. 2012;27(10):2039–46. doi:10.1002/jbmr.1698.CrossRef Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney Jr RE, McLellan A, et al. Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res Off J Am Soc Bone Miner Res. 2012;27(10):2039–46. doi:10.​1002/​jbmr.​1698.CrossRef
15.
Zurück zum Zitat Jha S, Wang Z, Laucis N, Bhattacharyya T. Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996-2012: an ecological analysis. J Bone Miner Res Off J Am Soc Bone Miner Res. 2015;30(12):2179–87. doi:10.1002/jbmr.2565.CrossRef Jha S, Wang Z, Laucis N, Bhattacharyya T. Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996-2012: an ecological analysis. J Bone Miner Res Off J Am Soc Bone Miner Res. 2015;30(12):2179–87. doi:10.​1002/​jbmr.​2565.CrossRef
16.
Zurück zum Zitat • Kim SC, Kim DH, Mogun H, Eddings W, Polinski JM, Franklin JM, et al. Impact of the U.S. Food and Drug Administration’s safety-related announcements on the use of bisphosphonates after hip fracture. J Bone Miner Res Off J Am Soc Bone Miner Res. 2016;31(8):1536–40. doi:10.1002/jbmr.2832. Bisphosphonate use after a hip fracture declined from 15% to 3% (2004-2013) and bisphosphonate use, but not other osteoporotic meciation, was negatively affected by FDA announcements regarding side effects. CrossRef • Kim SC, Kim DH, Mogun H, Eddings W, Polinski JM, Franklin JM, et al. Impact of the U.S. Food and Drug Administration’s safety-related announcements on the use of bisphosphonates after hip fracture. J Bone Miner Res Off J Am Soc Bone Miner Res. 2016;31(8):1536–40. doi:10.​1002/​jbmr.​2832. Bisphosphonate use after a hip fracture declined from 15% to 3% (2004-2013) and bisphosphonate use, but not other osteoporotic meciation, was negatively affected by FDA announcements regarding side effects. CrossRef
17.
Zurück zum Zitat Gambacciani M, Levancini M. Management of postmenopausal osteoporosis and the prevention of fractures. Panminerva Med. 2014;56(2):115–31.PubMed Gambacciani M, Levancini M. Management of postmenopausal osteoporosis and the prevention of fractures. Panminerva Med. 2014;56(2):115–31.PubMed
20.
Zurück zum Zitat Philipp LM. Osteoporosis and pathologic bone. In: Ricci WM, Ostrum RF, editors. Orthopaedic. Knowledge Update: Trauma; 2016. Philipp LM. Osteoporosis and pathologic bone. In: Ricci WM, Ostrum RF, editors. Orthopaedic. Knowledge Update: Trauma; 2016.
21.
Zurück zum Zitat Molvik H, Khan W. Bisphosphonates and their influence on fracture healing: a systematic review. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2015;26(4):1251–60. doi:10.1007/s00198-014-3007-8.CrossRef Molvik H, Khan W. Bisphosphonates and their influence on fracture healing: a systematic review. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2015;26(4):1251–60. doi:10.​1007/​s00198-014-3007-8.CrossRef
23.
Zurück zum Zitat Bhadada SK, Sridhar S, Muthukrishnan J, Mithal A, Sharma DC, Bhansali A, et al. Predictors of atypical femoral fractures during long term bisphosphonate therapy: a case series & review of literature. Indian J Med Res. 2014;140(1):46–54.PubMedPubMedCentral Bhadada SK, Sridhar S, Muthukrishnan J, Mithal A, Sharma DC, Bhansali A, et al. Predictors of atypical femoral fractures during long term bisphosphonate therapy: a case series & review of literature. Indian J Med Res. 2014;140(1):46–54.PubMedPubMedCentral
26.
Zurück zum Zitat Miyakoshi N, Aizawa T, Sasaki S, Ando S, Maekawa S, Aonuma H, et al. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. J Bone Miner Metab. 2015;33(5):553–9. doi:10.1007/s00774-014-0617-3.CrossRefPubMed Miyakoshi N, Aizawa T, Sasaki S, Ando S, Maekawa S, Aonuma H, et al. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. J Bone Miner Metab. 2015;33(5):553–9. doi:10.​1007/​s00774-014-0617-3.CrossRefPubMed
27.
Zurück zum Zitat • Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, et al. Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res Off J Am Soc Bone Miner Res. 2016;31(1):16–35. doi:10.1002/jbmr.2708. Management of long term bisphosphonate use should include drug holidays after 3-5 years of continuous use depending on the mode of administration. CrossRef • Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, et al. Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res Off J Am Soc Bone Miner Res. 2016;31(1):16–35. doi:10.​1002/​jbmr.​2708. Management of long term bisphosphonate use should include drug holidays after 3-5 years of continuous use depending on the mode of administration. CrossRef
28.
Zurück zum Zitat • Gedmintas L, Solomon DH, Kim SC. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J Bone Miner Res Off J Am Soc Bone Miner Res. 2013;28(8):1729–37. doi:10.1002/jbmr.1893. Meta-analysis providing a link between atypical femur fractures and long term bisphosphonate use. CrossRef • Gedmintas L, Solomon DH, Kim SC. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J Bone Miner Res Off J Am Soc Bone Miner Res. 2013;28(8):1729–37. doi:10.​1002/​jbmr.​1893. Meta-analysis providing a link between atypical femur fractures and long term bisphosphonate use. CrossRef
29.
Zurück zum Zitat Egol KA, Park JH, Rosenberg ZS, Peck V, Tejwani NC. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails. Clin Orthop Relat Res. 2014;472(9):2728–34. doi:10.1007/s11999-013-2963-1.CrossRefPubMed Egol KA, Park JH, Rosenberg ZS, Peck V, Tejwani NC. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails. Clin Orthop Relat Res. 2014;472(9):2728–34. doi:10.​1007/​s11999-013-2963-1.CrossRefPubMed
30.
Zurück zum Zitat • Miller AN, Lake AF, Emory CL. Establishing a fracture liaison service: an orthopaedic approach. J Bone Joint Surg Am. 2015;97(8):675–81. doi:10.2106/jbjs.n.00957. Fracture Liaison Services are an important aspect of osteoporosis management with proven benefits to the patient. Article provides a potential model for success involving a coordinator, physician champion (supports an orthopaedic surgeon), and a nurse navigator. CrossRefPubMed • Miller AN, Lake AF, Emory CL. Establishing a fracture liaison service: an orthopaedic approach. J Bone Joint Surg Am. 2015;97(8):675–81. doi:10.​2106/​jbjs.​n.​00957. Fracture Liaison Services are an important aspect of osteoporosis management with proven benefits to the patient. Article provides a potential model for success involving a coordinator, physician champion (supports an orthopaedic surgeon), and a nurse navigator. CrossRefPubMed
31.
33.
Zurück zum Zitat Judge A, Javaid MK, Leal J, Hawley S, Drew S, Sheard S et al. Health Services and Delivery Research. Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England. Southampton (UK): NIHR Journals Library Copyright (c) Queen’s Printer and Controller of HMSO 2016. This work was produced by Judge et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.; 2016. Judge A, Javaid MK, Leal J, Hawley S, Drew S, Sheard S et al. Health Services and Delivery Research. Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England. Southampton (UK): NIHR Journals Library Copyright (c) Queen’s Printer and Controller of HMSO 2016. This work was produced by Judge et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.; 2016.
35.
Zurück zum Zitat Huntjens KM, van Geel TA, van den Bergh JP, van Helden S, Willems P, Winkens B, et al. Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality. J Bone Joint Surg Am. 2014;96(4):e29. doi:10.2106/jbjs.l.00223.CrossRefPubMed Huntjens KM, van Geel TA, van den Bergh JP, van Helden S, Willems P, Winkens B, et al. Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality. J Bone Joint Surg Am. 2014;96(4):e29. doi:10.​2106/​jbjs.​l.​00223.CrossRefPubMed
37.
Zurück zum Zitat Eekman DA, van Helden SH, Huisman AM, Verhaar HJ, Bultink IE, Geusens PP, et al. Optimizing fracture prevention: the fracture liaison service, an observational study. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014;25(2):701–9. doi:10.1007/s00198-013-2481-8.CrossRef Eekman DA, van Helden SH, Huisman AM, Verhaar HJ, Bultink IE, Geusens PP, et al. Optimizing fracture prevention: the fracture liaison service, an observational study. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014;25(2):701–9. doi:10.​1007/​s00198-013-2481-8.CrossRef
38.
Zurück zum Zitat Yates CJ, Chauchard MA, Liew D, Bucknill A, Wark JD. Bridging the osteoporosis treatment gap: performance and cost-effectiveness of a fracture liaison service. Journal of clinical densitometry: the official journal of the International Society for Clinical Densitometry. 2015;18(2):150–6. doi:10.1016/j.jocd.2015.01.003.CrossRef Yates CJ, Chauchard MA, Liew D, Bucknill A, Wark JD. Bridging the osteoporosis treatment gap: performance and cost-effectiveness of a fracture liaison service. Journal of clinical densitometry: the official journal of the International Society for Clinical Densitometry. 2015;18(2):150–6. doi:10.​1016/​j.​jocd.​2015.​01.​003.CrossRef
39.
Zurück zum Zitat Fraser M. Using nurse-led liaison to prevent further fractures. Nurs Times. 2014;110(27):12–4.PubMed Fraser M. Using nurse-led liaison to prevent further fractures. Nurs Times. 2014;110(27):12–4.PubMed
40.
Zurück zum Zitat Yong JH, Masucci L, Hoch JS, Sujic R, Beaton D. Cost-effectiveness of a fracture liaison service—a real-world evaluation after 6 years of service provision. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016;27(1):231–40. doi:10.1007/s00198-015-3280-1.CrossRef Yong JH, Masucci L, Hoch JS, Sujic R, Beaton D. Cost-effectiveness of a fracture liaison service—a real-world evaluation after 6 years of service provision. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016;27(1):231–40. doi:10.​1007/​s00198-015-3280-1.CrossRef
41.
42.
Zurück zum Zitat Wyller TB, Watne LO, Torbergsen A, Engedal K, Frihagen F, Juliebo V, et al. The effect of a pre- and post-operative orthogeriatric service on cognitive function in patients with hip fracture. The protocol of the Oslo Orthogeriatrics Trial BMC geriatrics. 2012;12:36. doi:10.1186/1471-2318-12-36.PubMed Wyller TB, Watne LO, Torbergsen A, Engedal K, Frihagen F, Juliebo V, et al. The effect of a pre- and post-operative orthogeriatric service on cognitive function in patients with hip fracture. The protocol of the Oslo Orthogeriatrics Trial BMC geriatrics. 2012;12:36. doi:10.​1186/​1471-2318-12-36.PubMed
44.
Zurück zum Zitat Leal J, Gray AM, Hawley S, Prieto-Alhambra D, Delmestri A, Arden NK, et al. Cost-effectiveness of Orthogeriatric and fracture liaison service models of Care for hip Fracture Patients: a population-based study. J Bone Miner Res Off J Am Soc Bone Miner Res. 2016; doi:10.1002/jbmr.2995. Leal J, Gray AM, Hawley S, Prieto-Alhambra D, Delmestri A, Arden NK, et al. Cost-effectiveness of Orthogeriatric and fracture liaison service models of Care for hip Fracture Patients: a population-based study. J Bone Miner Res Off J Am Soc Bone Miner Res. 2016; doi:10.​1002/​jbmr.​2995.
45.
Zurück zum Zitat Hawley S, Javaid MK, Prieto-Alhambra D, Lippett J, Sheard S, Arden NK, et al. Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study. Age Ageing. 2016;45(2):236–42. doi:10.1093/ageing/afv204.CrossRefPubMedPubMedCentral Hawley S, Javaid MK, Prieto-Alhambra D, Lippett J, Sheard S, Arden NK, et al. Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study. Age Ageing. 2016;45(2):236–42. doi:10.​1093/​ageing/​afv204.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Giles M, Van Der Kallen J, Parker V, Cooper K, Gill K, Ross L, et al. A team approach: implementing a model of care for preventing osteoporosis related fractures. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2011;22(8):2321–8. doi:10.1007/s00198-010-1466-0.CrossRef Giles M, Van Der Kallen J, Parker V, Cooper K, Gill K, Ross L, et al. A team approach: implementing a model of care for preventing osteoporosis related fractures. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2011;22(8):2321–8. doi:10.​1007/​s00198-010-1466-0.CrossRef
47.
Zurück zum Zitat Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D, Calcium. The National Academies Collection: Reports funded by National Institutes of Health. In: Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US) National Academy of Sciences. 2011. Institute of Medicine Committee to Review Dietary Reference Intakes for Vitamin D, Calcium. The National Academies Collection: Reports funded by National Institutes of Health. In: Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US) National Academy of Sciences. 2011.
48.
Zurück zum Zitat Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014;25(10):2359–81. doi:10.1007/s00198-014-2794-2.CrossRef Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2014;25(10):2359–81. doi:10.​1007/​s00198-014-2794-2.CrossRef
49.
Zurück zum Zitat Pro-Risquez A, Harris SS, Song L, Rudicel S, Barnewolt B, Dawson-Hughes B. Calcium supplement and osteoporosis medication use in women and men with recent fractures. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2004;15(9):689–94. doi:10.1007/s00198-004-1668-4.CrossRef Pro-Risquez A, Harris SS, Song L, Rudicel S, Barnewolt B, Dawson-Hughes B. Calcium supplement and osteoporosis medication use in women and men with recent fractures. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2004;15(9):689–94. doi:10.​1007/​s00198-004-1668-4.CrossRef
50.
Zurück zum Zitat • Weaver CM, Alexander DD, Boushey CJ, Dawson-Hughes B, Lappe JM, LeBoff MS, et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016;27(1):367–76. doi:10.1007/s00198-015-3386-5. Meta-analysis supporting the continued use of both Calcium and Vitamin D supplemenation. CrossRef • Weaver CM, Alexander DD, Boushey CJ, Dawson-Hughes B, Lappe JM, LeBoff MS, et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016;27(1):367–76. doi:10.​1007/​s00198-015-3386-5. Meta-analysis supporting the continued use of both Calcium and Vitamin D supplemenation. CrossRef
51.
Zurück zum Zitat Harvey NC, Biver E, Kaufman JM, Bauer J, Branco J, Brandi ML, et al. The role of calcium supplementation in healthy musculoskeletal ageing : an expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF). Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016; doi:10.1007/s00198-016-3773-6. Harvey NC, Biver E, Kaufman JM, Bauer J, Branco J, Brandi ML, et al. The role of calcium supplementation in healthy musculoskeletal ageing : an expert consensus meeting of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Foundation for Osteoporosis (IOF). Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016; doi:10.​1007/​s00198-016-3773-6.
53.
Zurück zum Zitat Cesareo R, Iozzino M, D’Onofrio L, Terrinoni I, Maddaloni E, Casini A, et al. Effectiveness and safety of calcium and vitamin D treatment for postmenopausal osteoporosis. Minerva Endocrinol. 2015;40(3):231–7.PubMed Cesareo R, Iozzino M, D’Onofrio L, Terrinoni I, Maddaloni E, Casini A, et al. Effectiveness and safety of calcium and vitamin D treatment for postmenopausal osteoporosis. Minerva Endocrinol. 2015;40(3):231–7.PubMed
54.
Zurück zum Zitat Tai V, Leung W, Grey A, Reid IR, Bolland MJ. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ (Clinical research ed). 2015;351:h4183. doi:10.1136/bmj.h4183. Tai V, Leung W, Grey A, Reid IR, Bolland MJ. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ (Clinical research ed). 2015;351:h4183. doi:10.​1136/​bmj.​h4183.
55.
Zurück zum Zitat Bolland MJ, Leung W, Tai V, Bastin S, Gamble GD, Grey A, et al. Calcium intake and risk of fracture: systematic review. BMJ (Clinical research ed). 2015;351:h4580. doi:10.1136/bmj.h4580. Bolland MJ, Leung W, Tai V, Bastin S, Gamble GD, Grey A, et al. Calcium intake and risk of fracture: systematic review. BMJ (Clinical research ed). 2015;351:h4580. doi:10.​1136/​bmj.​h4580.
57.
Zurück zum Zitat • Anderson J, Kruszka B, Delany J, He K, Burke G, Alonso A et al. Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification and its Progression Among Older Adults: 10-Year Follow-Up of the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of the American Heart Association. 2016; 5(10). Significant link between calcium and atherosclerosis, but no link to MI. • Anderson J, Kruszka B, Delany J, He K, Burke G, Alonso A et al. Calcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification and its Progression Among Older Adults: 10-Year Follow-Up of the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of the American Heart Association. 2016; 5(10). Significant link between calcium and atherosclerosis, but no link to MI.
58.
Zurück zum Zitat Raffield LM, Agarwal S, Hsu FC, de Boer IH, Ix JH, Siscovick D, et al. The association of calcium supplementation and incident cardiovascular events in the multi-ethnic study of atherosclerosis (MESA). Nutrition, metabolism, and cardiovascular diseases: NMCD. 2016;26(10):899–907. doi:10.1016/j.numecd.2016.07.007.CrossRefPubMed Raffield LM, Agarwal S, Hsu FC, de Boer IH, Ix JH, Siscovick D, et al. The association of calcium supplementation and incident cardiovascular events in the multi-ethnic study of atherosclerosis (MESA). Nutrition, metabolism, and cardiovascular diseases: NMCD. 2016;26(10):899–907. doi:10.​1016/​j.​numecd.​2016.​07.​007.CrossRefPubMed
59.
Zurück zum Zitat Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). J Clin Endocrinol Metab. 2012;97(2):614–22. doi:10.1210/jc.2011-1309.CrossRefPubMed Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial). J Clin Endocrinol Metab. 2012;97(2):614–22. doi:10.​1210/​jc.​2011-1309.CrossRefPubMed
60.
Zurück zum Zitat Lewis JR, Calver J, Zhu K, Flicker L, Prince RL. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2011;26(1):35–41. doi:10.1002/jbmr.176.CrossRef Lewis JR, Calver J, Zhu K, Flicker L, Prince RL. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2011;26(1):35–41. doi:10.​1002/​jbmr.​176.CrossRef
61.
Zurück zum Zitat Chung M, Tang AM, Fu Z, Wang DD, Newberry SJ. Calcium intake and cardiovascular disease risk: an updated systematic review and meta-analysis. Ann Intern Med. 2016;165(12):856–66. doi:10.7326/m16-1165.CrossRefPubMed Chung M, Tang AM, Fu Z, Wang DD, Newberry SJ. Calcium intake and cardiovascular disease risk: an updated systematic review and meta-analysis. Ann Intern Med. 2016;165(12):856–66. doi:10.​7326/​m16-1165.CrossRefPubMed
63.
Zurück zum Zitat • Kopecky SL, Bauer DC, Gulati M, Nieves JW, Singer AJ, Toth PP, et al. Lack of evidence linking calcium with or without vitamin D supplementation to cardiovascular disease in generally healthy adults: a clinical guideline from the National Osteoporosis Foundation and the American Society for Preventive Cardiology. Ann Intern Med. 2016;165(12):867–8. doi:10.7326/m16-1743. Lack of evidence to link calcium supplementation to cardiovascular disease. CrossRefPubMed • Kopecky SL, Bauer DC, Gulati M, Nieves JW, Singer AJ, Toth PP, et al. Lack of evidence linking calcium with or without vitamin D supplementation to cardiovascular disease in generally healthy adults: a clinical guideline from the National Osteoporosis Foundation and the American Society for Preventive Cardiology. Ann Intern Med. 2016;165(12):867–8. doi:10.​7326/​m16-1743. Lack of evidence to link calcium supplementation to cardiovascular disease. CrossRefPubMed
64.
Zurück zum Zitat Karlsson L, Lundkvist J, Psachoulia E, Intorcia M, Strom O. Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2015;26(10):2401–11. doi:10.1007/s00198-015-3253-4.CrossRef Karlsson L, Lundkvist J, Psachoulia E, Intorcia M, Strom O. Persistence with denosumab and persistence with oral bisphosphonates for the treatment of postmenopausal osteoporosis: a retrospective, observational study, and a meta-analysis. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2015;26(10):2401–11. doi:10.​1007/​s00198-015-3253-4.CrossRef
66.
Zurück zum Zitat Lee S, Glendenning P, Inderjeeth CA. Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2011;22(3):741–53. doi:10.1007/s00198-010-1335-x.CrossRef Lee S, Glendenning P, Inderjeeth CA. Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2011;22(3):741–53. doi:10.​1007/​s00198-010-1335-x.CrossRef
67.
68.
Zurück zum Zitat Devine J, Trice S, Finney Z, Yarger S, Nwokeji E, Linton A, et al. A retrospective analysis of extended-interval dosing and the impact on bisphosphonate compliance in the US military health system. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2012;23(4):1415–24. doi:10.1007/s00198-011-1729-4.CrossRef Devine J, Trice S, Finney Z, Yarger S, Nwokeji E, Linton A, et al. A retrospective analysis of extended-interval dosing and the impact on bisphosphonate compliance in the US military health system. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2012;23(4):1415–24. doi:10.​1007/​s00198-011-1729-4.CrossRef
69.
Zurück zum Zitat Kolata G. Osteoporosis, a disease with few treatment options. New York Times: May Soon Have One More; 2016. Kolata G. Osteoporosis, a disease with few treatment options. New York Times: May Soon Have One More; 2016.
72.
Zurück zum Zitat Isogai Y, Takao-Kawabata R, Takakura A, Sugimoto E, Nakazono O, Ikegaki I, et al. Early effects of single and low-frequency repeated administration of teriparatide, hPTH(1-34), on bone formation and resorption in ovariectomized rats. Calcif Tissue Int. 2015;97(4):412–20. doi:10.1007/s00223-015-0026-1.CrossRefPubMedPubMedCentral Isogai Y, Takao-Kawabata R, Takakura A, Sugimoto E, Nakazono O, Ikegaki I, et al. Early effects of single and low-frequency repeated administration of teriparatide, hPTH(1-34), on bone formation and resorption in ovariectomized rats. Calcif Tissue Int. 2015;97(4):412–20. doi:10.​1007/​s00223-015-0026-1.CrossRefPubMedPubMedCentral
73.
Zurück zum Zitat • Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, et al. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA. 2016;316(7):722–33. doi:10.1001/jama.2016.11136. Abaloparatide is a potentially new anabolic drug that could provide an alternative to teriparatide, and has been shown to be effective in preventing osteoporotic fractures. CrossRefPubMed • Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, et al. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA. 2016;316(7):722–33. doi:10.​1001/​jama.​2016.​11136. Abaloparatide is a potentially new anabolic drug that could provide an alternative to teriparatide, and has been shown to be effective in preventing osteoporotic fractures. CrossRefPubMed
75.
Zurück zum Zitat Papapoulos S, Lippuner K, Roux C, Lin CJ, Kendler DL, Lewiecki EM, et al. The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM extension study. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2015;26(12):2773–83. doi:10.1007/s00198-015-3234-7.CrossRef Papapoulos S, Lippuner K, Roux C, Lin CJ, Kendler DL, Lewiecki EM, et al. The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM extension study. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2015;26(12):2773–83. doi:10.​1007/​s00198-015-3234-7.CrossRef
77.
Zurück zum Zitat Miller PD, Pannacciulli N, Brown JP, Czerwinski E, Nedergaard BS, Bolognese MA, et al. Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates. J Clin Endocrinol Metab. 2016;101(8):3163–70. doi:10.1210/jc.2016-1801.CrossRefPubMedPubMedCentral Miller PD, Pannacciulli N, Brown JP, Czerwinski E, Nedergaard BS, Bolognese MA, et al. Denosumab or zoledronic acid in postmenopausal women with osteoporosis previously treated with oral bisphosphonates. J Clin Endocrinol Metab. 2016;101(8):3163–70. doi:10.​1210/​jc.​2016-1801.CrossRefPubMedPubMedCentral
78.
Zurück zum Zitat Sheedy KC, Camara MI, Camacho PM. Comparison of the efficacy, adverse effects, and cost of zoledronic acid and denosumab in the treatment of osteoporosis. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2015;21(3):275–9. doi:10.4158/ep14106.or.CrossRef Sheedy KC, Camara MI, Camacho PM. Comparison of the efficacy, adverse effects, and cost of zoledronic acid and denosumab in the treatment of osteoporosis. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2015;21(3):275–9. doi:10.​4158/​ep14106.​or.CrossRef
79.
Zurück zum Zitat • Zhou Z, Chen C, Zhang J, Ji X, Liu L, Zhang G, et al. Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis. Int J Clin Exp Pathol. 2014;7(5):2113–22. Denosumab significantly decreases the risk of non-vertebral osteoporotic fractures, but was associated with a higher rate of infection. PubMedPubMedCentral • Zhou Z, Chen C, Zhang J, Ji X, Liu L, Zhang G, et al. Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis. Int J Clin Exp Pathol. 2014;7(5):2113–22. Denosumab significantly decreases the risk of non-vertebral osteoporotic fractures, but was associated with a higher rate of infection. PubMedPubMedCentral
80.
Zurück zum Zitat Bone HG, Chapurlat R, Brandi ML, Brown JP, Czerwinski E, Krieg MA, et al. The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension. J Clin Endocrinol Metab. 2013;98(11):4483–92. doi:10.1210/jc.2013-1597.CrossRefPubMedPubMedCentral Bone HG, Chapurlat R, Brandi ML, Brown JP, Czerwinski E, Krieg MA, et al. The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension. J Clin Endocrinol Metab. 2013;98(11):4483–92. doi:10.​1210/​jc.​2013-1597.CrossRefPubMedPubMedCentral
82.
Zurück zum Zitat Farooki A, Fornier M, Boland P. Atypical femur fractures associated with use of bisphosphonates and denosumab. Annals of oncology: official journal of the European Society for Medical Oncology. 2015;26(4):819–20. doi:10.1093/annonc/mdv014.CrossRef Farooki A, Fornier M, Boland P. Atypical femur fractures associated with use of bisphosphonates and denosumab. Annals of oncology: official journal of the European Society for Medical Oncology. 2015;26(4):819–20. doi:10.​1093/​annonc/​mdv014.CrossRef
83.
Zurück zum Zitat Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2014;29(1):1–23. doi:10.1002/jbmr.1998.CrossRef Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2014;29(1):1–23. doi:10.​1002/​jbmr.​1998.CrossRef
84.
Zurück zum Zitat Tsai JN, Uihlein AV, Lee H, Kumbhani R, Siwila-Sackman E, McKay EA, et al. Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet (London, England). 2013;382(9886):50–6. doi:10.1016/s0140-6736(13)60856-9.CrossRef Tsai JN, Uihlein AV, Lee H, Kumbhani R, Siwila-Sackman E, McKay EA, et al. Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet (London, England). 2013;382(9886):50–6. doi:10.​1016/​s0140-6736(13)60856-9.CrossRef
85.
Zurück zum Zitat Tsai JN, Uihlein AV, Burnett-Bowie SM, Neer RM, Derrico NP, Lee H, et al. Effects of two years of teriparatide, denosumab, or both on bone microarchitecture and strength (DATA-HRpQCT study). J Clin Endocrinol Metab. 2016;101(5):2023–30. doi:10.1210/jc.2016-1160.CrossRefPubMedPubMedCentral Tsai JN, Uihlein AV, Burnett-Bowie SM, Neer RM, Derrico NP, Lee H, et al. Effects of two years of teriparatide, denosumab, or both on bone microarchitecture and strength (DATA-HRpQCT study). J Clin Endocrinol Metab. 2016;101(5):2023–30. doi:10.​1210/​jc.​2016-1160.CrossRefPubMedPubMedCentral
86.
Zurück zum Zitat Tsai JN, Uihlein AV, Burnett-Bowie SA, Neer RM, Zhu Y, Derrico N, et al. Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT study. J Bone Miner Res Off J Am Soc Bone Miner Res. 2015;30(1):39–45. doi:10.1002/jbmr.2315.CrossRef Tsai JN, Uihlein AV, Burnett-Bowie SA, Neer RM, Zhu Y, Derrico N, et al. Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT study. J Bone Miner Res Off J Am Soc Bone Miner Res. 2015;30(1):39–45. doi:10.​1002/​jbmr.​2315.CrossRef
87.
Zurück zum Zitat Bansal S, Pecina JL, Merry SP, Kennel KA, Maxson J, Quigg S, et al. US preventative services task force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2015;26(4):1429–33. doi:10.1007/s00198-015-3026-0.CrossRef Bansal S, Pecina JL, Merry SP, Kennel KA, Maxson J, Quigg S, et al. US preventative services task force FRAX threshold has a low sensitivity to detect osteoporosis in women ages 50-64 years. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2015;26(4):1429–33. doi:10.​1007/​s00198-015-3026-0.CrossRef
89.
Zurück zum Zitat Gillespie CW, Morin PE. Trends and disparities in osteoporosis screening among women in the United States, 2008-2014: declines in utilization among women 50 to 64 years old and persistent underutilization among women 65 and older. Am J Med. 2016; doi:10.1016/j.amjmed.2016.10.018.PubMed Gillespie CW, Morin PE. Trends and disparities in osteoporosis screening among women in the United States, 2008-2014: declines in utilization among women 50 to 64 years old and persistent underutilization among women 65 and older. Am J Med. 2016; doi:10.​1016/​j.​amjmed.​2016.​10.​018.PubMed
90.
Zurück zum Zitat Office of the Surgeon G. Reports of the Surgeon General. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville (MD): Office of the Surgeon General (US); 2004. Office of the Surgeon G. Reports of the Surgeon General. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville (MD): Office of the Surgeon General (US); 2004.
92.
Zurück zum Zitat Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NF, McCloskey EV, et al. Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016;27(1):21–31. doi:10.1007/s00198-015-3145-7.CrossRef Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NF, McCloskey EV, et al. Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016;27(1):21–31. doi:10.​1007/​s00198-015-3145-7.CrossRef
94.
Zurück zum Zitat Burch J, Rice S, Yang H, Neilson A, Stirk L, Francis R, et al. Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups. Health technology assessment (Winchester, England). 2014;18(11):1–180. doi:10.3310/hta18110. Burch J, Rice S, Yang H, Neilson A, Stirk L, Francis R, et al. Systematic review of the use of bone turnover markers for monitoring the response to osteoporosis treatment: the secondary prevention of fractures, and primary prevention of fractures in high-risk groups. Health technology assessment (Winchester, England). 2014;18(11):1–180. doi:10.​3310/​hta18110.
95.
Zurück zum Zitat Cavalier E, Bergmann P, Bruyere O, Delanaye P, Durnez A, Devogelaer JP, et al. The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian bone Club. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016;27(7):2181–95. doi:10.1007/s00198-016-3561-3.CrossRef Cavalier E, Bergmann P, Bruyere O, Delanaye P, Durnez A, Devogelaer JP, et al. The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian bone Club. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2016;27(7):2181–95. doi:10.​1007/​s00198-016-3561-3.CrossRef
96.
Zurück zum Zitat Luo Y, Hu Z, Hao J, Jiang W, Shen J, Zhao J. Significant associations between the A163G and G1181C polymorphisms of the osteoprotegerin gene and risk of osteoporosis, especially in postmenopausal women: a meta-analysis. Genetic testing and molecular biomarkers. 2014;18(3):211–9. doi:10.1089/gtmb.2013.0420.CrossRefPubMed Luo Y, Hu Z, Hao J, Jiang W, Shen J, Zhao J. Significant associations between the A163G and G1181C polymorphisms of the osteoprotegerin gene and risk of osteoporosis, especially in postmenopausal women: a meta-analysis. Genetic testing and molecular biomarkers. 2014;18(3):211–9. doi:10.​1089/​gtmb.​2013.​0420.CrossRefPubMed
98.
Zurück zum Zitat Kanis JA. Assessment of Osteoporosis at the Primary Health-Care Level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Disease. In: University of Sheffield U, editor.: University of Sheffield; 2007. Kanis JA. Assessment of Osteoporosis at the Primary Health-Care Level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Disease. In: University of Sheffield U, editor.: University of Sheffield; 2007.
99.
Zurück zum Zitat • Nordin C. Screening for osteoporosis: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2011;155(4):276. doi:10.7326/0003-4819-155-4-201108160-00021. Current recommendations regarding Osteoporosis Screening, with USPSTF recommendations as well as recommendations of other entities and colleges like the National Osteoporosis Foundation. CrossRefPubMed • Nordin C. Screening for osteoporosis: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2011;155(4):276. doi:10.​7326/​0003-4819-155-4-201108160-00021. Current recommendations regarding Osteoporosis Screening, with USPSTF recommendations as well as recommendations of other entities and colleges like the National Osteoporosis Foundation. CrossRefPubMed
100.
Zurück zum Zitat Nayak S, Greenspan SL. Cost-effectiveness of osteoporosis screening strategies for men. J Bone Miner Res Off J Am Soc Bone Miner Res. 2016;31(6):1189–99. doi:10.1002/jbmr.2784.CrossRef Nayak S, Greenspan SL. Cost-effectiveness of osteoporosis screening strategies for men. J Bone Miner Res Off J Am Soc Bone Miner Res. 2016;31(6):1189–99. doi:10.​1002/​jbmr.​2784.CrossRef
Metadaten
Titel
Osteoporosis: a discussion on the past 5 years
verfasst von
Kyle M. Schweser
Brett D. Crist
Publikationsdatum
07.04.2017
Verlag
Springer US
Erschienen in
Current Reviews in Musculoskeletal Medicine / Ausgabe 2/2017
Elektronische ISSN: 1935-9748
DOI
https://doi.org/10.1007/s12178-017-9410-y

Weitere Artikel der Ausgabe 2/2017

Current Reviews in Musculoskeletal Medicine 2/2017 Zur Ausgabe

Social Media and Orthopedics (P Sculco, section editor)

Social media: physicians-to-physicians education and communication

Social Media and Orthopedics (P Sculco, section editor)

The future of social media in orthopedic surgery

Motion Preserving Spine Surgery (C Kepler, section editor)

Cervical disc replacement surgery: indications, technique, and technical pearls

Orthopaedic Health Policy (A Miller, section editor)

Pay-for-performance in orthopedics: how we got here and where we are going

Motion Preserving Spine Surgery (C Kepler, section editor)

Lumbar disc replacement surgery—successes and obstacles to widespread adoption

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.